EP2694087
Meðhöndlun sýkingar með sermiguluveiru einni og sér eða í samsetningu með lifrabólgu delta veiru og tengdra lifrarsjúkdóma
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
30.3.2012EP published:
28.1.2015EP application number:
12713680.2
EP translation filed:
11.3.2015Grant published:
15.4.2015EPO information:
European Patent Register
Max expiry date:
29.3.2032Expiry date:
29.3.2017
Title:
TREATMENT FOR INFECTION WITH HEPATITIS B VIRUS ALONE OR IN COMBINATION WITH HEPATITIS DELTA VIRUS AND ASSOCIATED LIVER DISEASES
Timeline
Today
30.3.2012EP application
28.1.2015EP Publication
11.3.2015Translation submitted
15.4.2015Registration published
29.3.2017Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
NAOUMOV, NikolaiAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161470666 PDate:
1.4.2011Country:
US
Classification
Categories:
A61K 38/13, A61P 31/20, A61P 31/14, A61P 1/16
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 11.3.2015
Expires: 29.3.2016
Payer: Árnason Faktor
Number: 5
Paid: 10.2.2016
Expires: 29.3.2017
Payer: Árnason Faktor